FDA Exempted Federal Drug Testing Systems
The agency removed premarket notification requirements for 14 categories of clinical toxicology test systems.
Updated on Oct. 7, 2026 in Substance Abuse
Live Poll
Do you support the transition to oral fluid drug testing for federally regulated commercial drivers?
The FDA finalized an order removing the 510(k) premarket notification requirement for 14 categories of clinical toxicology test systems used in federal drug testing. This regulatory change aims to reduce administrative burdens and costs for manufacturers.
Why it matters
By eliminating 510(k) submission requirements, the FDA aims to streamline the regulatory process for manufacturers of toxicology testing systems. This shift is a necessary step to facilitate the expansion of oral fluid testing alternatives under Department of Transportation regulations.
The FDA finalized the exemption for 14 categories of clinical toxicology test systems following feedback from approximately 70 commenters. This action removes costs associated with 510(k) premarket notifications.
The players
Food and Drug Administration
This federal agency is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs and biological products.
Department of Transportation
This federal department establishes the regulations governing transportation safety and manages the drug and alcohol testing requirements for safety-sensitive employees.
Department of Health and Human Services
This cabinet-level department oversees federal health programs and maintains the certification process for laboratories conducting drug testing.
The details
The FDA order simplifies the path to market for diagnostic tools, though urine remains the only currently approved testing method for DOT-regulated employers. To adopt oral fluid testing, employers must wait for the certification of at least two HHS-certified laboratories to handle primary and split specimens.
Timeline
In 2023, the DOT authorized oral fluid as a testing alternative.
The FDA proposed the exemption change in May 2026.
The FDA finalized the order on October 6, 2026.
Health Landscape
This regulatory update follows the framework set by the Department of Transportation oral fluid testing authorization. The FDA's order functions as an extension of that policy by removing barriers to the laboratory infrastructure required for broader testing implementation.
While this change applies to employer-regulated drug testing rather than personal medical care, it will eventually allow workers to undergo oral fluid testing instead of urine-based methods. Readers should monitor their employers for updates regarding the availability of this new testing format.
The takeaway
The FDA's decision marks a significant shift in how federal laboratories will be equipped for drug screening. Employers should prepare for an transition period as the industry shifts toward utilizing oral fluid testing systems.
What happens next
The Department of Transportation will publish a Federal Register notice announcing an 18-month transition period for observed collections.
Further reading
Find more information on testing protocols in the Substance Abuse section.
Live Poll
Do you support the transition to oral fluid drug testing for federally regulated commercial drivers?
